Back

Tailoring the clinical approach: who will benefit from innovative lipid-lowering therapies?

1 September 2024 (13:05 - 13:15)
Organised by: Logo
Congress Presentation Part of: Sustained LDL-C reduction: from long-term trials to real-world implementation Lipid-Lowering Agents Open Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Derek Connolly

Midland Metropolitan University Hospital, Smethwick (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor K. Ray (London, GB)
Presentation thumbnail
Bridging guidelines to practice: why patients remain outside of LDL-C goals
Assistant Professor S. Kohsaka (Tokyo, JP)
Presentation thumbnail
Value of sustained LDL-C lowering: learnings from long-term data
Professor K. Ray (London, GB)
Presentation thumbnail
Real-world and implementation science: insights about siRNA
Doctor C. Ballantyne (Houston, US)
Presentation thumbnail
Panel discussion
Professor K. Ray (London, GB) Assistant Professor S. Kohsaka (Tokyo, JP) Doctor C. Ballantyne (Houston, US) Professor D. Connolly (Smethwick, GB)

Access the full session

Session thumbnail
Sustained LDL-C reduction: from long-term trials to real-world implementation

The Event

Event poster

ESC Congress 2024

1 September 2024 13:05 CET
You may be interested in
thumbnail
Congress Presentation
Real-world and implementation science: insights about siRNA
thumbnail
Congress Session
Sustained LDL-C reduction: from long-term trials to real-world implementation
thumbnail
Congress Presentation
Panel discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources